Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Prostate and Urologic Cancer
Sponsor
National Cancer Institute (NCI)
Status
Completed
NCT ID
NCT01433913
This randomized phase II trial studies how well metformin hydrochloride works compared to placebo in treating patients with prostate cancer undergoing surgery. Metformin hydrochloride may make some enzymes active. These enzymes may block other enzymes needed for cell growth and stop the growth of tumor cells.
Intervention
laboratory biomarker analysis, metformin hydrochloride, placebo
Condition
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer
Investigators
Robert Krouse